Hu Xue Feng - Net Worth and Insider Trading
Hu Xue Feng Net Worth
The estimated net worth of Hu Xue Feng is at least $362,160 dollars as of 2025-04-27. Hu Xue Feng is the senior management of Nanjing Pharmaceutical Co Ltd and owns about 72,000 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) stock worth over $362,160. Details can be seen in Hu Xue Feng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hu Xue Feng has not made any transactions after 2008-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hu Xue Feng
Hu Xue Feng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hu Xue Feng owns 1 companies in total, including Nanjing Pharmaceutical Co Ltd (SHSE:600713) .
Click here to see the complete history of Hu Xue Feng’s form 4 insider trades.
Insider Ownership Summary of Hu Xue Feng
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600713 | Nanjing Pharmaceutical Co Ltd | 2008-11-10 | senior management |
Hu Xue Feng Latest Holdings Summary
Hu Xue Feng currently owns a total of 1 stock. Hu Xue Feng owns 72,000 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) as of November 10, 2008, with a value of $362,160.
Latest Holdings of Hu Xue Feng
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600713 | Nanjing Pharmaceutical Co Ltd | 2008-11-10 | 72,000 | 5.03 | 362,160 |
Holding Weightings of Hu Xue Feng
Hu Xue Feng Form 4 Trading Tracker
According to the SEC Form 4 filings, Hu Xue Feng has made a total of 0 transactions in Nanjing Pharmaceutical Co Ltd (SHSE:600713) over the past 5 years. The most-recent trade in Nanjing Pharmaceutical Co Ltd is the acquisition of 24,000 shares on November 10, 2008, which cost Hu Xue Feng around $47,200.
Insider Trading History of Hu Xue Feng
- 1
Hu Xue Feng Trading Performance
GuruFocus tracks the stock performance after each of Hu Xue Feng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hu Xue Feng is -6.15%. GuruFocus also compares Hu Xue Feng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hu Xue Feng within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hu Xue Feng's insider trading performs compared to the benchmark.
Performance of Hu Xue Feng
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.46 | | | | | |
| Relative Return to S&P 500(%) | 15.12 | | | | | |
Hu Xue Feng Ownership Network
Ownership Network List of Hu Xue Feng
Ownership Network Relation of Hu Xue Feng
Hu Xue Feng Owned Company Details
What does Nanjing Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing Pharmaceutical Co Ltd?
Hu Xue Feng is the senior management of Nanjing Pharmaceutical Co Ltd. Other key executives at Nanjing Pharmaceutical Co Ltd include senior management xiao hong , senior management peng yu ping , and Supervisors She Ping .
Nanjing Pharmaceutical Co Ltd (SHSE:600713) Insider Trades Summary
Over the past 18 months, Hu Xue Feng made no insider transaction in Nanjing Pharmaceutical Co Ltd (SHSE:600713). Other recent insider transactions involving Nanjing Pharmaceutical Co Ltd (SHSE:600713) include a net purchase of 7,100 shares made by xiao hong ,
In summary, during the past 3 months, insiders sold 0 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) were sold and 7,100 shares were bought by its insiders, resulting in a net purchase of 7,100 shares.
Nanjing Pharmaceutical Co Ltd (SHSE:600713)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing Pharmaceutical Co Ltd Insider Transactions
Hu Xue Feng Mailing Address
Above is the net worth, insider trading, and ownership report for Hu Xue Feng. Currently GuruFocus does not have mailing address information for Hu Xue Feng.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
